Article

Press Release

Central Florida Cancer Care Center/Radiation Oncology Consultants Joins FCS

Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Central Florida Cancer Care Center/Radiation Oncology Consultants, PA has joined the statewide practice.

Nathan H. Walcker

Nathan H. Walcker

Fort Myers, Fla., September 1, 2023 – Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Central Florida Cancer Care Center/Radiation Oncology Consultants, PA has joined the statewide practice, effective September 1, 2023.

Nathan H. Walcker, FCS Chief Executive Officer, said, “Across Florida, we continue to add and enhance services so that patients can easily access world-class cancer treatment close to home. This partnership will provide many benefits for the Central Florida community, our patients and our clinic teams.”

Board-certified radiation oncologists Maneesh Gossain, MD, Richard Lee, MD and Steven G. Lester, MD, FACRO will continue to provide care to patients at two existing locations, renamed as FCS Orlando Radiation Oncology at 52 W. Gore Street, Orlando, FL 32806 and FCS Sanford Radiation Oncology at 2200 W. 1st Street, Sanford, FL 32771.

“The size and scope of FCS will enable us to expand the range of sophisticated treatment therapies that are improving survival rates for many forms of cancer,” said Dr. Gossain. “Inhouse capabilities such as extensive next-generation testing and access to cutting-edge clinical trials will enhance our ability to develop personalized treatment plans that target each patient’s unique cancer.”

“These physicians have an extraordinary depth and breadth of experience in delivering evidence-based radiation oncology treatments and are equally well regarded for their compassion and concern for patients and their families,” said FCS President & Managing Physician Lucio N. Gordan, MD. “We are delighted to welcome them to FCS.”

Teams from the two practices have been working collaboratively in recent months to ensure a smooth transition with no disruption in patient care. “Treatment and care plans will remain consistent and uninterrupted,” said Dr. Lester.

Related Videos
Cesar Augusto Perez, MD
Experts on lung cancer
Expert on lung cancer
Expert on lung cancer
Expert on lung cancer
Expert on lung cancer
Experts on lung cancer
Expert on lung cancer
Expert on lung cancer
Expert on skin cancer